Life ScienceCompany
Exelixis M&A Summary
Exelixis has acquired 3 companies, including 1 in the last 5 years.
Exelixis’ largest acquisition to date was in 2021, when it acquired GamaMabs Pharma - AMHR2 Antibody Technology for $5M. Exelixis has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).
Exelixis Business Overview
Where is Exelixis headquartered?
Exelixis is headquartered in Alameda, California.
What is Exelixis’ revenue?
Exelixis disclosed revenue of 1,830M USD for 2023 and 1,611M USD for 2022.
How many employees does Exelixis have?
Exelixis has 1,310 employees.
What sector is Exelixis in?
Exelixis is a life science company.
When was Exelixis founded?
Exelixis was founded in 1994.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 1